Starpharmaの売上総利益
Starpharmaの売上総利益 は何ですか。
Starpharma Holdings Limitedの売上総利益 は-9.52%です。
売上総利益 の定義は何ですか。
売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
ASXのセクタHealth Careにおける売上総利益 の企業と比べるStarpharma
Starpharmaは何をしますか。
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Starpharmaと類似の売上総利益
- Anglo Asian Mining Plcの売上総利益 は-9.73%です。
- Altima Resourcesの売上総利益 は-9.66%です。
- Champion Technologyの売上総利益 は-9.65%です。
- Velodyne Lidarの売上総利益 は-9.55%です。
- Sanwaria Consumerの売上総利益 は-9.54%です。
- Ur-の売上総利益 は-9.54%です。
- Starpharmaの売上総利益 は-9.52%です。
- Televista SAの売上総利益 は-9.30%です。
- Yuzhou Propertiesの売上総利益 は-9.29%です。
- Avecho Biotechnologyの売上総利益 は-9.28%です。
- Nutraplus Indiaの売上総利益 は-9.27%です。
- CNIM S.Aの売上総利益 は-9.21%です。
- Olympique Lyonnais e SAの売上総利益 は-9.19%です。